beta-lapachone has been researched along with Diabetes Mellitus in 1 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, PY | 1 |
| Lai, SY | 1 |
| Su, YT | 1 |
| Yang, KC | 1 |
| Chau, YP | 1 |
| Don, MJ | 1 |
| Lu, KH | 1 |
| Shy, HT | 1 |
| Lai, SM | 1 |
| Kung, HN | 1 |
1 other study available for beta-lapachone and Diabetes Mellitus
| Article | Year |
|---|---|
β-Lapachone, an NQO1 activator, alleviates diabetic cardiomyopathy by regulating antioxidant ability and mitochondrial function.
Topics: Animals; Antioxidants; Diabetes Mellitus; Diabetic Cardiomyopathies; Mice; Mice, Inbred C57BL; Mitoc | 2022 |